TrendingWallStreet.com Releases Coverage on OCLS, EXPR, ABIO, and VTMB


Follow this company

Companies Mentioned

NASDAQ:OCLS / NYSE:EXPR / OTC:BB:VTMB / NASDAQ:VTMB
12/05/2013 [ACCESSWIRE]

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/  to get exclusive access to our free stock reports.

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) shares closed up over 100 percent on Wednesday on about 17.8 million shares traded. The stock hit a 52-week high of 7.21 during intra-day trading and one of the largest percentage increases on the NASDAQ. The company announced that it has received a new 510(k) clearance from the FDA for the company's new Microcyn Scar Management HydroGel.

Get more information on Oculus Innovative Sciences, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/OCLS                  

Express Inc. (NYSE: EXPR) shares closed down 22.98 percent on Wednesday with over 20.8 million shares traded. The stock was one of the biggest droppers on the NYSE. The company reported that it earned 23 cents a share in the third quarter, up 15% from last year but 2 cents below views. Revenue rose 7% to $503 million, topping forecasts for $499.7 million. The Company expects Q4 EPS of 66-71 cents, well below consensus estimates for 78 cents. It lowered its full-year profit outlook to $1.46-$1.51 a share from $1.52$1.60. Analysts were looking for $1.61.

Get more information on Express Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/EXPR 

ARCA biopharma, Inc. (NASDAQ: ABIO) shares closed up 25.01 percent on Wednesday with nearly 25 million shares traded. ARCA biopharma announced that the Company’s GencaroTM Investigational New Drug (IND) application for atrial fibrillation (AF) has been accepted by the U.S. Food and Drug Administration (FDA) and is now active.

Get more information on ARCA biopharma, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/ABIO                     

Vitamin Blue, Inc. (OTCBB: VTMB) shares closed up 160 percent on Wednesday on nearly 330 million shares traded. The stock was one of the biggest gainers in the OTCBB market. The Company announced that it has received its first order from a company owned by Mark Cuban, and featured on Shank Tank. CEO Frank Ornelas comments, "This is a historic day for Vitamin Blue as we begin working with the premier direct manufacturer SUP Company.

Get more information on Vitamin Blue, Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/VTMB

 

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *